What is Oracea?
Oracea is a branded form of doxycycline, a type of tetracycline antibiotic. It can help to heal sore, itchy, and inflamed hair follicles caused by folliculitis.
The capsules contain a โnon-antibioticโ dose, which means that unlike higher doses of the same active ingredient that work as antibiotics, they can be used long-term to manage inflamed hair follicles.
Who is Oracea for?
Oracea is usually prescribed for adults with rosacea, but it can also be prescribed โoff-labelโ for folliculitis.
Folliculitis often occurs as a result of hair follicles becoming inflamedโ this can happen as a result of viral and bacterial infections, but also as a result of inflammation or blocked pores. Bacterial infections are the most common cause of folliculitis.[1]
Why is Oracea prescribed โoff-labelโ?
Off-label prescribing is when medications are used outside of their stated license. Itโs a common practice, and done if a prescriber thinks using a medication this way will work effectively.
Oracea would typically be used when folliculitis symptoms are severe.[2]
How does Oracea work?
Tetracycline antibiotics like Oracea work by reducing inflammation.
Your physician might prescribe Oracea to help reduce soreness and inflammation, which can help unclog infected follicles and allow the surrounding skin to heal.
Does Oracea come in different doses?
Oracea comes as a single dose, 40mg capsule.
The capsules contain 30mg doxycycline which hits your stomach soon after youโve taken it, and another 10mg is released when the medication reaches your small intestine a few hours later. This low-dose formula means you can take Oracea for longer than you typically would with the usual 100mg doses of doxycycline.
How we source info.
When we present you with stats, data, opinion or a consensus, weโll tell you where this came from. And weโll only present data as clinically reliable if itโs come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.